Myfortic 360mg Tablet

Myfortic 360mg Tablet is an immunosuppressive drug. It contains Mycophenolate Sodium. It is primarily used to prevent rejection of transplanted organs. It suppresses the activity of the immune system, so it doesn’t attack the organ transplanted.

Uses of Myfortic 360mg Tablet: Prevention of Organ Rejection

How does Myfortic 360mg Tablet work?

Mycophenolate sodium is an inhibitor of an enzyme which stimulates the growth of lymphocytes, immune cells which attack foreign tissue.Mycophenolate lowers immunological responses by reducing the creation of lymphocytes, which helps to keep the body from rejecting the transplanted organ.

How to Use & Dosage?

Dosages can vary depending on the transplant organ and patient requirements, but for kidney transplant recipients, the usual recommendation is 720 mg twice a day. taken orally, unless directed otherwise by your health professional, preferably on an empty stomach for best absorption.

Read the Medication Guide provided by your pharmacist before you start taking mycophenolate, and each time you get a refill. Ask your pharmacist or physician if you have any questions. Usually this medication is taken by mouth twice a day on an empty stomach, one hour before or two hours after meals, as directed by your doctor.

Do not break the medicine. Do not crush or chew. Do not open the capsules before swallowing when you are taking them.Your dose depends on your medical condition and how you respond to treatment. In addition, the dose for children depends on their body size.
To get the most benefit from this drug, take it every day. Take it daily at the same time to help with memory.

Possible Side Effects:

• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Leukopenia (low white blood cell count)
• Anemia
• Headache
• Dizziness
• Fatigue

Safety Advise:

Kidney

Those who have a history of renal problems should be careful when using Mycofit as it may lead to other kidney related problems. Please talk with your healthcare provider.

Liver

Patients with a history of liver disease should be cautious while taking Mycofit as it may cause other liver related problems. Please consult your healthcare provider.

Pregnancy

Do not take Mycofit 360mg Tablets if you are pregnant as it may harm the fetus. Please talk to your health care professional.

Breastfeeding

It is not known if the 360mg Mycofit tablet passes into your breast milk or affects your breast milk. If you take this medicine, ask your doctor how to feed your child in the best way for his or her health.

Alcohol

You should not take Mycofit 360 Tablet with alcohol as it may lead to unwanted side effects. Please talk to your health care provider.

Storage Instructions:

Store at 20°C to 25°C (68°F to 77°F). Store in tight containers, protected from moisture and light.

Frequently Asked Questions (FAQs):

1. What is Myfortic 360mg Tablet used for?

It is used to prevent rejection of a kidney, liver, or heart after a transplant.

2. What is the price of Myfortic 360mg Tablet ?

In India, it normally costs anywhere from Rs 680 to Rs 950.

3.Can Myfortic be taken long-term?

Yes, it is commonly used as long-term immunosuppressive therapy after transplantation.

4.Is Myfortic safe during pregnancy?

No, it can be very bad during pregnancy and should only be taken under medical supervision.

References:

• Tripathi KD. Immunosuppressive Drugs. In: Essentials of Medical Pharmacology. 8th ed. New Delhi: Jaypee Brothers Medical Publishers; 2019.
• Brunton LL, Hilal-Dandan R, Knollmann BC, eds. Immunosuppressants, Tolerogens, and Immunostimulants. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 13th ed. New York: McGraw-Hill Education; 2018.
• Novartis Pharmaceuticals Corporation. Myfortic (mycophenolate sodium) delayed-release tablets: full prescribing information. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2022.
• Kim M, Rostas S, Gabardi S. Mycophenolate fetal toxicity and risk evaluation and mitigation strategies. American Journal of Transplantation. 2013;13(6):1383-1389.
• Salvadori M, Holzer H, de Mattos A, et al. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. American Journal of Transplantation. 2004;4(2):231-236.

Disclaimer:

IHS Enterprises’s primary objective is to guarantee the accuracy, reliability, and specialist review of the information it provides to customers. The contents and information provided on this website are for informational purposes only. They should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician for guidance and any questions you may have about any condition or medication. If you do read anything from IHS Enterprises, please do not discount or delay in seeking competent medical advice. We want to enhance the doctor-patient relationship, not substitute it.